Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesInsulin detemir alert issued by FDA
American Pharmacists Association, 06/15/09
FDA announced that some stolen vials of the basal insulin product Levemir have reappeared and are being sold on the U.S. market. Pharmacists should remove vials with the following lot numbers of this insulin detemir product from inventory: XZF0036, XZF0037, and XZF0038. One report of a patient who suffered an adverse event due to poor control of glucose levels after using a vial from one of these three lots has been reported to FDA.
Today in Drug/Product Alerts...keeping you current
Receive free subspecialty "5-minute updates" via email
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN
Allos Therapeutics, 12/01/09
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Archives of Neurology, 11/23/09
Sponsor
Article Search
Sponsor